Navigation Links
Carboplatin, Lung cancer drug may be useful in treating breast tumor

If breast cancer in women has occurred because of two common genetic mutations, it may be possible to seek remedy from a prevalent chemotherapy medication. Carboplatin, which is being used// to treat ovarian and lung cancers, is getting known for its success rates in treating breast tumors.

British scientists have conducted a research on mice which has revealed that cancer cells with BRCA2 mutations are twenty times more receptive to carboplatin, and that BRCA1 tumors are between five and twenty times more receptive.

The scientists will be testing this finding on 150 BRCA breast cancer patients, 75 with each mutation, who will be administered carboplatin or docetaxel, to check out which one is more effective. If the clinical trials prove successful, then it will be used to treat breast cancer patients with BRCA mutations within 5 years.

Andrew Tutt, consultant oncologist at Guy’s and St Thomas’ NHS Foundation Trust in London, who is leading the trial, said: “There is an increasing realisation that breast cancer is not just one disease, but that different types of tumor will respond differently to particular drugs. This genetically tailored chemotherapy treatment acts in a much more focused manner than standard chemotherap.”
'"/>




Page: 1

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Want skin cancer? Please have a cigarette
3. New hope for cancer victims – will vaccine cure the deadly bug
4. Clintons new problem - Is the outgoing American president suffering from skin cancer?
5. Are cancer patients being taken for a ride?
6. Breast cancer treatment to be determined by gene test
7. Ductal lavage may detect early breast cancer
8. Beware of the oral patch! It could be cancer!!!
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
Post Your Comments:
Breaking Medicine Technology:New Executive Leadership and CEO Announced for BiPar Sciences 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 1Nonin Medical Recognized for Influential Contributions in Medical Technology 5845 2PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 1PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 2PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 3PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 4PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 5PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 6PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 7PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 8PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 9PRO DEX INC Announces Fiscal First Quarter 2010 Profit Update on Business Development Activities and Renewal of Banking Agreement 5843 10Perrigo Company Announces Dividend Increase 5841 1